Askbio Inc., a subsidiary of Bayer AG, has received IND clearance from the FDA for AB-1009, an AAV gene therapy being developed for the treatment of late-onset Pompe disease.

AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...

Nick Kroll comedy 'A Hundred Percent' has gotten a series order at Netflix. Kroll stars along with Sam Richardson, Jason ...

President Donald Trump recently said he takes more aspirin to thin his blood than doctors usually recommend, noting he's ...

Trump takes four times the recommended dose of aspirin for cardiac prevention. Even low-dose aspirin is no longer recommended ...

President Donald Trump, 79, says he takes a higher daily dose of aspirin than his doctors recommend, a choice he says ...

In one of his most candid interviews about his age, President Trump disclosed the ways he manages his health, several of which go against the advice of his doctors.  Speaking to The Wall Street ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump refuses to give up aspirin habit ...

Trump’s decision to take a higher daily dose highlights the balance between preventive benefits and increased risks such as ...

President Trump told the Wall Street Journal that he has been taking higher doses of aspirin for "cardiac prevention" for ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...